Aller au contenu principal
Profil bibliographique

John Crowley

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

582Publications signalées
60383Citations signalées
0Affiliations récentes

Les domaines associés

Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer Treatment and PharmacologyLung Cancer Treatments and MutationsStatistical Methods in Clinical Trials

Les publications récentes

Accès ouvert 2026 article OpenAlex

Métodos diagnósticos para la detección de infección por Helicobater pylori en un establecimiento de primer nivel de atención

Manuel Valdivieso Rodríguez, Ronald Malca Collazos, Benjamín Ramos Rojas, Jorge Ríos Pérez et autres

Introduction. The detection of Helicobacter pylori infection is essential for the prevention of gastric-origin diseases, especially stomach cancer, which has a high prevalence in Peru. Methods. An observational study was conducted in a primary care facility in Chincha, Peru, through the review …

0 citations Anales de la Facultad de Medicina
2025 book-chapter OpenAlex

Phase III Trials for Targeted Agents

Antje Hoering, Michael Leo LeBlanc, John Crowley

The paradigm of cancer research has been changing and cancer therapies with new mechanisms of action from conventional chemotherapies are being developed. Conventional chemotherapies are also often known as cytotoxic agents; they utilize various mechanisms important in mitosis to kill dividing cells, …

0 citations
2025 book-chapter OpenAlex

Phase II Trials with Multiple Strata

Michael Leo LeBlanc, Cathryn J. Rankin, John Crowley

Some newer oncology treatments, such as immunotherapies, have broad efficacy across multiple tumor types. These treatments have resulted in trial designs that have increasingly focused on approaches that treat multiple subtypes of a single cancer using the same treatment, while analyzing results …

0 citations
Accès ouvert 2025 article OpenAlex

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial

David Robert Spigel, Virginie Westeel, Ian C. Anderson, Laurent Greillier et autres

BACKGROUND: Survival for non-small-cell lung cancer (NSCLC) remains unacceptably low, even in stage IA-IIA. Current guidelines recommend adjuvant treatment for patients considered to be at high risk in stages IB and IIA, but suggest criteria that have not been validated to predict …

us, fr, de (code pays fourni par la source)

12 citations The Lancet Respiratory Medicine
2025 conference-abstract OpenAlex

DOP099 Prolonged Pharmacodynamic Effects of Risankizumab Following Withdrawal in Patients with Moderately to Severely Active Ulcerative Colitis

D T Rubin, Jessica Ravikoff Allegretti, Ryan DeMasi, John Crowley et autres

Abstract Background Risankizumab (RZB) is a high-affinity humanized IgG1 monoclonal antibody that selectively binds to the p19 subunit of human IL-23 cytokine, thereby inhibiting its interaction with the IL-23 receptor.1 RZB was intentionally designed with modifications to the antibody that could contribute …

us (code pays fourni par la source)

0 citations Journal of Crohn s and Colitis
Accès ouvert 2024 article OpenAlex

How Does the Pre-Registration Midwifery Programme Prepare the Newly Qualified Midwives for Their Post-Registration Perinatal Mental Health Role? A Mixed Methods Study

Yemi Onilude, Omorogieva Ojo, David Thomas Evans, John Crowley et autres

Objective: In the United Kingdom (UK) and most countries worldwide, midwives are professionally required to undertake an initial perinatal mental health (PMH) risk assessment at every maternity contact. However, studies have found that midwives feel that they are not well-equipped to provide …

gb (code pays fourni par la source)

1 citation Healthcare

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.